# David T. Rubin

David T. Rubin (born 6 March 1968) is an American Gastroenterologist and Educator. He is the Joseph B. Kirsner Professor of Medicine and Professor of Pathology at the University of Chicago, where he is also the Chief of the Section of Gastroenterology, Hepatology and Nutrition. He also serves as the Director of the Inflammatory Bowel Disease group at the University of Chicago. He is also an associate faculty member at the MacLean Center for Clinical Medical Ethics, associate investigator at the University of Chicago Comprehensive Cancer Center and a member of the University of Chicago Committee on Clinical Pharmacology and Pharmacogenomics.

## Education and training

David T. Rubin obtained his Doctor of Medicine degree with honors at the University of Chicago Pritzker School of Medicine. He went on to complete his internship, residency, and fellowship at the University of Chicago where he served as Chief Resident and Chief Fellow. He also completed a fellowship in Clinical Medical Ethics at the MacLean Center for Clinical Medical Ethics and a leadership development course at the Harvard T.H. Chan School of Public Health.

## Career

David T. Rubin specializes in the treatment and assessment of inflammatory bowel diseases (Crohn's disease and ulcerative colitis).
Dr. Rubin performs scientific research related to outcomes in inflammatory bowel diseases with particular interest in the prevention of cancer associated with these diseases and strategies to modify the disease course and control inflammation. He is involved in the design and execution of clinical trials for new therapies in inflammatory bowel diseases.
Dr. Rubin is a Fellow of the American Gastroenterological Association (AGAF), the American College of Gastroenterology (FACG), the American Society for Gastrointestinal Endoscopy (FASGE), the American College of Physicians (FACP), and the Royal College of Physicians in Edinburgh (FRCP (Edinburgh)). Dr. Rubin is a Co-Founder (with Dr. Marla Dubinsky) of Cornerstones Health, Inc, a non-profit medical education organization. He is the immediate past chair of the National Scientific Advisory Committee of Crohn's & Colitis Foundation and Deputy Chair of the International Organization for the Study of IBD.

## Selected works and publications

Dr. Rubin is the editor of Curbside Consultation in IBD: 49 Clinical Questions, third edition and an editor of Sleisenger and Fordtran's Gastrointestinal and Liver Disease, twelfth edition. He is an associate editor of the journals of Intestinal Research, Inflammatory Bowel Diseases and Gastroenterology & Hepatology, and co-editor of the ACG Education Universe.
* AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary. Rubin DT, Feuerstein JD, Wang AY, Cohen RD. Gastroenterology. 2020;159(1):350-357.
* ACG Clinical Guideline: Ulcerative Colitis in Adults. Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. Am J Gastroenterol. 2019;114:384-413.
* Safety and efficacy of combination treatment with calcineurin inhibitors and vedolizumab in patients with refractory inflammatory bowel disease. Christensen B, Gibson P, Micic D, Colman RJ, Goeppinger S, Kassim O, Yarur A, Weber C, Cohen RD, Rubin DT. Clin Gastroenterol Hepatol. 2019;17(3):486-493.
* Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes. Christensen B, Hanauer SB, Erlich J, Kassim O, Gibson PR, Turner JR, Hart J, Rubin DT.  Clin Gastroenterol Hepatol. 2017;5:1557-64.
* The Crohn's and Colitis Foundation of America Survey of Inflammatory Bowel Disease Patient Healthcare Access.  Rubin DT, Feld LD, Goeppinger S, Kim S, Margolese JM, Rosh J, Rubin M, Rodriquez DM, Wingate L.  Inflamm Bowel Dis.  2017;23:224-32.
* Using a Treat-to-Target Management Strategy to Improve the Doctor-Patient Relationship in Inflammatory Bowel Disease. Rubin DT, Krugliak Cleveland N.  Am J Gastroenterol. 2015;110:1252-6.
* Ethical Consideration for Clinical Trials in Inflammatory Bowel Disease.  Rubin DT, Becker S, Siegler M.  Gastroenterol Hepatol. 2014;10:37-41.
* Inflammation is an Independent Risk Factor for Colonic Neoplasia in Patients with Ulcerative Colitis: A Case-Control Study. Rubin DT, Huo D, Kinnucan JA, Sedrak MS, McCullom NE, Bunnag AP, Raun-Royer EP, Cohen RD, Hanauer SB, Hart J, Turner JR.  Clin Gastroenterol Hepatol.  2013;11:1601-8.

## Honors and awards

| Arthur H. Rubenstein Mentorship in Academic Medicine Award | 2023 |
| Michael Reese Lectureship Award | 2022 |
| Recipient of the Champion of Mission Advancement by the Crohn’s & Colitis Foundation - Illinois Carol Fisher Chapter | 2022 |
| Recipient of the GI Research Foundation’s Joseph B. Kirsner Award | 2022 |
| Nominee, the Women in Medicine Summit #HeforShe Award | 2021 |
| Sherman Prize Recipient | 2020 |
| Dr. Joseph B.  Kirsner  Mentorship Award  (Given by the Senior Fellows) | 2012, 2020 |
| John D. Arnold, MD Mentor Award for sustained excellence in mentoring a Pritzker medical student, University of Chicago  (mentorship of Laura Glick, class of 2019) | 2018 – 2019 |
| Fellow, University of Chicago Pritzker School of Medicine Academy of Distinguished Medical Educators | 2009 – 2018 |
| Inaugural Social Media Influencer Award, Healio Disruptive Innovators Awards | 2018 |
| Crohn's  &  Colitis Foundation  Uniting to Care & Cure Award, Catalyst for Policy Change. | 2018 |
| Lifetime Achievement Award, Brazilian Association for Ulcerative Colitis and Crohn's disease | 2017 |
| Julius J.  Deren  Invited Lectureship  Optimizing the Use of Therapies for IBD: Current Status and Vision for the Future.  University of Pennsylvania Grand Rounds (CME), Philadelphia, PA | 2015 |
| Selected by Becker's ASC Review as one of the leading 191 Gastroenterologists in the United States | 2015 |
| Sir Francis Avery Jones Visiting Professor:  New Goals for IBD Management – Do They Translate to Better Outcomes?   Frontiers in Intestinal and Colorectal Disease, 13th  Annual International Congress St. Mark's Hospital, Harrow UK | 2015 |
| Peer-elected,  Castle Connolly Top Doctor in Gastroenterology | 2013 – 2014 |
| American Journal of Gastroenterology lectureship: “The emerging role of the microbiome in the pathogenesis and management of inflammatory bowel disease” | 2013 |
| “Ginzburg-Oppenheimer Invited Lecturer”, Mt. Sinai Medical Center (NYC)    (Ginzburg and Oppenheimer were the other others on the Landmark original Crohn's disease paper.) | 2013 |
| American College of Gastroenterology Governor's Award of Excellence in Clinical Research | 2003, 2013 |
| Peer-elected Member of  Best Doctors, recognition for superior clinical abilities | 2001, 2007–2013 |
| ACG Freshman Governors’ Award | 2012 |
| Recipient of Rosenthal Award, the Crohn's  &  Colitis Foundation's National Leadership Award for Patient Support and Care (presented to the volunteer who demonstrates uncommon leadership and has contributed in an indisputable way to the quality of life of patients and families through patient service, professional education and advocacy). | 2012 |
| Selected to be honored by the Crohn's  &  Colitis Foundation of America Illinois Chapter for contributions to the CCFA and patients with IBD at their annual benefit dinner | 2012 |
| Bucksbaum  Institute Senior Faculty Scholar Award | 2012 |
| Voted by  Top Tier  MD as one of the top 3% of physicians in Chicago | 2011 |
| Selected by Becker's ASC Review as one of the leading 125 Gastroenterologists in the United States | 2011 |
| Selected by fellows to receive the 2010 Fellowship Teaching Award for being an outstanding teacher and role model | 2010 |
| Peer-elected Member of  America's Top Physicians, Gastroenterology | 2003, 2004, 2005, 2007 – 2008 |
| University of Chicago Postgraduate Teaching Award: in recognition of Significant Contributions for Fellowship Education | 2006 |
| Cancer Research Foundation Young Investigator Award | 2004 |
| Richard W. Reilly Award for outstanding aptitude in the field of gastroenterology | 1994 |
| Upjohn Award in Medicine, for outstanding achievement during four years in the Pritzker School of Medicine | 1994 |
| Alpha Omega Alpha honor society | 1993 |